These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21045689)

  • 41. Molecular genetic changes found in human lung cancer and its precursor lesions.
    Gazdar AF; Bader S; Hung J; Kishimoto Y; Sekido Y; Sugio K; Virmani A; Fleming J; Carbone DP; Minna JD
    Cold Spring Harb Symp Quant Biol; 1994; 59():565-72. PubMed ID: 7587113
    [No Abstract]   [Full Text] [Related]  

  • 42. Premalignant evolution of lung cancer: Gilles F Filley lecture.
    Franklin WA
    Chest; 2004 May; 125(5 Suppl):90S-4S. PubMed ID: 15136432
    [No Abstract]   [Full Text] [Related]  

  • 43. [Genetic susceptibility for lung cancer and nicotinic addiction: toward a molecular explanation?].
    Bergot E; Levallet G; Zalcman G
    Rev Mal Respir; 2008 May; 25(5):519-22. PubMed ID: 18535517
    [No Abstract]   [Full Text] [Related]  

  • 44. Genetic predisposition to lung cancer.
    Schwartz AG
    Chest; 2004 May; 125(5 Suppl):86S-9S. PubMed ID: 15136430
    [No Abstract]   [Full Text] [Related]  

  • 45. [Nicotinic acetylcholine receptor and chronic obstructive pulmonary disease].
    Dormoy V; Pons S; Gosset P; Maskos U
    Med Sci (Paris); 2022; 38(8-9):637-639. PubMed ID: 36094229
    [No Abstract]   [Full Text] [Related]  

  • 46. [Selected genetic aspects of lung cancer].
    Radzikowska E
    Pneumonol Alergol Pol; 1993; 61(9-10):539-44. PubMed ID: 8111334
    [No Abstract]   [Full Text] [Related]  

  • 47. Another brick in the wall.
    Paschoal ME; Lapa e Silva JR
    Sao Paulo Med J; 2002 Mar; 120(2):35. PubMed ID: 11994769
    [No Abstract]   [Full Text] [Related]  

  • 48. Nicotinic acetylcholine receptors mediate lung cancer growth.
    Improgo MR; Soll LG; Tapper AR; Gardner PD
    Front Physiol; 2013; 4():251. PubMed ID: 24062692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acetylcholine receptor pathway in lung cancer: New twists to an old story.
    Niu XM; Lu S
    World J Clin Oncol; 2014 Oct; 5(4):667-76. PubMed ID: 25302169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer.
    Chikova A; Bernard HU; Shchepotin IB; Grando SA
    Life Sci; 2012 Nov; 91(21-22):1103-8. PubMed ID: 22280835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes?
    Hajiasgharzadeh K; Sadigh-Eteghad S; Mansoori B; Mokhtarzadeh A; Shanehbandi D; Doustvandi MA; Asadzadeh Z; Baradaran B
    J Cell Physiol; 2019 Sep; 234(9):14666-14679. PubMed ID: 30701535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α7 nicotinic acetylcholine receptors in lung cancer.
    Wang S; Hu Y
    Oncol Lett; 2018 Aug; 16(2):1375-1382. PubMed ID: 30008813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma.
    Pal K; Hussain T; Xie H; Li S; Yang P; Mansfield A; Lou Y; Chowdhury S; Mukhopadhyay D
    Front Oncol; 2022; 12():959500. PubMed ID: 36072788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into the Mechanisms of Action of Proanthocyanidins and Anthocyanins in the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer.
    Alsharairi NA
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acetylcholine signaling system in progression of lung cancers.
    Friedman JR; Richbart SD; Merritt JC; Brown KC; Nolan NA; Akers AT; Lau JK; Robateau ZR; Miles SL; Dasgupta P
    Pharmacol Ther; 2019 Feb; 194():222-254. PubMed ID: 30291908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
    Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
    Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.
    Zienolddiny S; Skaug V
    Lung Cancer (Auckl); 2012; 3():1-14. PubMed ID: 28210120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.
    Halldén S; Sjögren M; Hedblad B; Engström G; Hamrefors V; Manjer J; Melander O
    J Intern Med; 2016 Apr; 279(4):388-98. PubMed ID: 26689306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Curcumin protects against nicotine-induced stress during protein malnutrition in female rat through immunomodulation with cellular amelioration.
    Maiti M; Chattopadhyay K; Verma M; Chattopadhyay B
    Mol Biol Rep; 2015 Dec; 42(12):1623-37. PubMed ID: 26559197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
    Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
    J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.